Skip to main content
Coronavirus (COVID-19): Latest updates.

Clinical Trial

GA101 clinical trail press release…

Posted on 9 December 2013 by Paul Brennan

There was a nice story on the BBC today about GA101, a new antibody targeting CD20 which is being used to treat CLL. Our own, Professor Chris Fegan gave quotes […]

Promising clinical results for new drug for CLL

Posted on 17 May 2013 by Stephen Man

Professor Chris Fegan featured in the media, after the announcement of promising results from a clinical trial of obinutuzumab (GA101) conducted in Cardiff. Click on the picture to watch the […]